Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

ADIR claims tachykinin antagonists

June 14, 1996

Dopamine D4 receptor ligands discovered by Pfizer

June 7, 1996

Clinical trials anticipated for CoCensys' and Ciba-Geigy's codeveloped EAA antagonist

June 7, 1996

Ciba-Geigy discloses glycine-site NMDA antagonists

June 7, 1996

BASF reports glutamate receptor antagonists

June 7, 1996

GR-205171: A non-peptide neurokinin NK1 antagonist

June 7, 1996

ADIR reports piperazines with affinity for sigma-receptors

June 7, 1996

Botulinum toxin type A: Treatment of choice for idiopathic cervical dystonia

June 7, 1996

Connective Therapeutics' peptide vaccine trial results presented

June 7, 1996

CellPro and Northwestern University commence first BMT clinical trial in MS patients

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...